Allogeneic bone marrow-derived mesenchymal stem cell therapy (Ottawa Hospital Research Institute)

N/A

Report date: 2023/01/12 15:30:03

Base Information

Drug NameAllogeneic bone marrow-derived mesenchymal stem cell therapy (Ottawa Hospital Research Institute)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsShock, Septic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Ottawa Hospital Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesThe Ottawa Hospital Research Institute

Inactive CompaniesN/A

Active IndicationsShock, Septic

Inactive IndicationsN/A

Other Information

ATC CodeN/A